New role at Meda Pharmaceuticals Richard Müller has been appointed to the role of Market Access Representative in the Sales Management department of specialty pharmaceutical company Meda. Mr Müller’s previous pharmaceutical experience includes working on contract for AstraZeneca, Bayer Schering Pharma and Sanofi-Aventis. His medical devices experience includes working as the National Sales Manager for a range of paediatric and phototherapy devices. Mr Müller will be responsible and accountable for the management of business projects to support the portfolio of brands promoted in the UK. Whilst based at Head Office, the role will require some time in the field with representatives and customers, so a degree of travel is involved. When asked to comment on his recent appointment, Mr Muller said: “This is a new post within Meda Pharma and I am looking forward to developing and implementing new initiatives to assist the growth of the UK product portfolio. There is a fresh and innovative outlook in Meda UK that differs from traditional big pharma.” He is an Affiliate Member of the Royal College of Paediatrics & Child Health, Associate Member of the Royal Society of Medicine and the Royal Society for Public Health, Member of the Institute of Health Promotion & Education and Fellow of the Royal Society of Tropical Medicine and Hygiene.	Editorial appointments at MGP MGP Ltd has made three new appointments within the Guidelines in Practice editorial team. Julia Morris has been promoted to Managing Editor of Guidelines in Practice and Connectmedical (the projects division of MGP), and May Lin Ang has been promoted to Sub Editor of Guidelines in Practice. These promotions reflect both Julia’s and May Lin’s high standard of work and commitment to the journal. Balraj Juttla joins the team as the Editorial Assistant of Guidelines in Practice. He brings writing and proof-reading experience to this role. Guidelines in Practice is the monthly clinical journal that helps GPs and other healthcare professionals practice evidence-based medicine and implement national guidelines locally. Its audience comprises 21,000 clinical decision makers at practices, PBC groups, and in primary care organisations. The continued success of Guidelines in Practice is underpinned by the ongoing NHS focus on the implementation of guidance to deliver a high-quality service to patients. MGP specialises in reaching primary care clinical decision makers, payers and influencers via high quality publications and through innovative educational projects.
Norgine appoints Business Development Director Specialty pharmaceutical company Norgine has appointed Dr. Adam Love as Director, Business Development, where he will report to Paul Pay, VP Corporate and Business Development. Most recently Adam was Director, European Business Development at Cephalon, and prior to that he was UK Medical Advisor at Cephalon. He is a qualified physician, having graduated from the University of the Witwatersrand Medical School in South Africa and also holds an MBA from Durham University. He has practised medicine in both South Africa and the UK. Norgine is an independent, European specialty pharmaceutical company that has been established for over 100 years and has a presence in all the major European markets. In 2007 Norgine’s sales were €220 million, the 21st consecutive year of double-digit growth. The company employs over 1,000 people, around 400 of which work in sales and marketing.	Academy offers support to new and aspiring managers Performance Coach Allan Mackintosh has launched the newly-created Brand New Manager Academy, which is dedicated to ensuring that new managers get the best possible start in their new management careers. The resources can also be used to support those aspiring managers on a succession plan, as well as support the development of existing managers who may not have had the requisite training needed for their role. Based around Allan’s ‘7 Levels of New Manager Excellence’ programme, the Academy offers a range of self-supported and supported study options ranging from a simple e-workbook download to 1:1 coaching and inhouse and open training courses. All options can lead to being awarded the ‘Certificate in New Manager Essential Skills’.
PanMedica appoints new Recruitment Manager Long-established industry recruitment agency PanMedica has appointed Helen Weller to the position of Recruitment Manager. Helen has more than five years’ experience working within the pharmaceutical and healthcare recruitment sector. Prior to joining the recruitment industry, Helen spent three years working in the pharmaceutical industry in medical sales. The company is pleased to have appointed Helen as she has the necessary experience, drive and determination to steer PanMedica in the direction it needs to go. In her career Helen has consistently proved her commitment to providing an exceptional service to clients and candidates alike. In addition to recruiting, she is managing a team of talented individuals who have brought a wealth of skills to the business. Helen places a strong emphasis on a high standard of training and development of her team so that they may deliver a premium service at all times. Helen gave us an insight into her intentions for the company: “PanMedica is in the fortunate position of providing sales and marketing recruitment services to a wide range of pharmaceutical and healthcare clients. Our focus for the next 12 months is to deliver a fast, efficient and professional service to candidates and clients alike.” “Helen is a superb asset to PanMedica and she is doing an excellent job. She has a refreshing outlook that is revitalising PanMedica,” said Jerry Meek, Managing Director. Training consultancy launched Dr Ravi K Powar has launched R11OSY Consultants Ltd, a new consultancy company specialising in training and coaching. The company will specialise in Research; Business Intelligence and Business Management; Implementing the Concept of the Learning Organisation; and Group and Individual Coaching. Another aspect will be the provision of training on ‘the Soft S’s’ – Style, Staff, Skills and Shared Values – to improve the performance of organisations. Ravi has a varied working history, holding management roles in various business domains alongside experience in the public and voluntary sector. Also an experienced lecturer, Ravi’s experience in coaching extends over twenty years. During a recent ten-year period Ravi has worked with various reputable companies in the pharmaceutical industry, having started her career with Innovex in 1997.	Strategic appointment for Penn Pharma Bioscience company Penn Pharma has appointed Darren Hassey as Operations Director at the company’s Welsh headquarters. Darren joins Penn with a wealth of experience within operations roles across the pharmaceutical industry spanning development, quality, in-licensing, manufacturing and operational excellence. Former Pharmaceutical Services Director Paul Thomas has taken on a new role as Chief Scientific Officer and former Commercial and Manufacturing Director John Roberts can now focus on the role of Commercial Director for Europe and the rest of the world. Speaking on his appointment Darren said: “I represent Penn at both executive and board level and am pleased to be able to bring with me more than 15 years experience in the industry. Although I am responsible for all operational areas including analytics, formulation, clinical trial supplies, logistics and manufacturing I will also maintain customer focus through leadership of the senior account managers.” Penn Chief Executive, Peter George, said: “Darren has a very strong background in the pharmaceutical sector and I’m confident that he is what Penn needs to continue to drive growth. He joins us following his seven-year career at Catalent, one of our competitors. Prior to this, Darren worked at GSK and AstraZeneca where he has built up an excellent reputation.”